Anticancer or carcinogenic? The role of estrogen receptor β in breast cancer progression
Article in Pharmacology & Therapeutics (January 2023)
The most recent citing publications are shown below. View all 48 publications that cite this research output on Dimensions.
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer
Article in Cancer Cell International (November 2022)
Enhanced ZNF521 expression induces an aggressive phenotype in human ovarian carcinoma cell lines
Article in PLOS ONE (October 2022)